High-dose budesonide for early COVID-19.

Berezowski, Ivan; Patel, Jigar; Shaw, Mariame; Pourmand, Ali

Berezowski, Ivan; Patel, Jigar; Shaw, Mariame; Pourmand, Ali.

Berezowski I; International Medicine Program, The George Washington University School of Medicine and Health Sciences, Washington, DC 20037, USA. Electronic address: iberezowski@gwu.edu.
Patel J; International Medicine Program, The George Washington University School of Medicine and Health Sciences, Washington, DC 20037, USA.
Shaw M; International Medicine Program, The George Washington University School of Medicine and Health Sciences, Washington, DC 20037, USA.
Pourmand A; International Medicine Program, The George Washington University School of Medicine and Health Sciences, Washington, DC 20037, USA.

Lancet ; 398(10317): 2146-2147, 2021 12 11.

Article in English | MEDLINE | ID: covidwho-1562142

Subject(s)

Budesonide; COVID-19; Administration, Inhalation; Bronchodilator Agents/therapeutic use; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Budesonide / COVID-19 Limits: Humans Language: English Journal: Lancet Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google